APA (7th ed.) Citation

Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, & Gil JP. (2020). Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment. Dove Medical Press.

Chicago Style (17th ed.) Citation

Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, and Gil JP. Prevalence of CYP2C8*2 and *3 Among Eritreans and Its Potential Impact on Artesunate/Amodiaquine Treatment. Dove Medical Press, 2020.

MLA (9th ed.) Citation

Habtemikael L, et al. Prevalence of CYP2C8*2 and *3 Among Eritreans and Its Potential Impact on Artesunate/Amodiaquine Treatment. Dove Medical Press, 2020.